First Western Trust Bank reduced its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 5.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,228 shares of the conglomerate’s stock after selling 2,013 shares during the period. Danaher makes up approximately 0.4% of First Western Trust Bank’s portfolio, making the stock its 24th largest position. First Western Trust Bank’s holdings in Danaher were worth $8,695,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of DHR. Fairfield Bush & CO. increased its stake in shares of Danaher by 10.9% during the 1st quarter. Fairfield Bush & CO. now owns 4,840 shares of the conglomerate’s stock worth $1,420,000 after purchasing an additional 475 shares in the last quarter. Zions Bancorporation N.A. boosted its position in Danaher by 19.3% during the first quarter. Zions Bancorporation N.A. now owns 2,468 shares of the conglomerate’s stock worth $724,000 after acquiring an additional 400 shares during the last quarter. Covestor Ltd boosted its position in Danaher by 76.8% during the first quarter. Covestor Ltd now owns 495 shares of the conglomerate’s stock worth $145,000 after acquiring an additional 215 shares during the last quarter. NewEdge Advisors LLC boosted its position in Danaher by 14.1% during the first quarter. NewEdge Advisors LLC now owns 31,530 shares of the conglomerate’s stock worth $9,248,000 after acquiring an additional 3,897 shares during the last quarter. Finally, Bridgewater Associates LP boosted its position in Danaher by 135.9% during the first quarter. Bridgewater Associates LP now owns 35,270 shares of the conglomerate’s stock worth $10,346,000 after acquiring an additional 20,320 shares during the last quarter. 76.71% of the stock is owned by hedge funds and other institutional investors.
Danaher Stock Up 0.5 %
Danaher stock traded up $1.08 during trading on Monday, reaching $208.86. 782,304 shares of the company’s stock were exchanged, compared to its average volume of 2,931,207. The company’s 50-day moving average is $217.93 and its two-hundred day moving average is $234.72. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.94 and a current ratio of 2.26. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $281.54. The firm has a market cap of $154.33 billion, a price-to-earnings ratio of 26.20, a PEG ratio of 2.08 and a beta of 0.81.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were issued a $0.27 dividend. The ex-dividend date was Wednesday, October 11th. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. Danaher’s dividend payout ratio is currently 13.62%.
Analysts Set New Price Targets
DHR has been the topic of a number of analyst reports. Royal Bank of Canada decreased their target price on shares of Danaher from $246.00 to $239.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 25th. The Goldman Sachs Group decreased their target price on shares of Danaher from $250.00 to $215.00 and set a “buy” rating on the stock in a research report on Thursday, October 26th. Bank of America raised their target price on shares of Danaher from $250.00 to $280.00 in a research report on Wednesday, July 26th. Raymond James decreased their price target on shares of Danaher from $250.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, October 25th. Finally, StockNews.com began coverage on shares of Danaher in a report on Wednesday, November 15th. They issued a “buy” rating on the stock. Three investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $257.73.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.
- Five stocks we like better than Danaher
- How to Use the MarketBeat Stock Screener
- Monday.com rocked earnings like it’s the weekend
- What Are the U.K. Market Holidays? How to Invest and Trade
- Plan to own one retailer? Make it this one
- Investing in Construction Stocks
- Target these 3 hot retail stocks for Black Friday deals
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.